Clinical trial
Prospective, Randomized, Double-blind, Controlled, Multicenter Study on the Efficacy and Safety of HES 130/0. 42 in a Balanced Electrolyte Solution vs a HES 130/0.4 in a Sodium Chloride Solution in Elective Surgery Patients
NCT01301469 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Double-blind, Controlled, Multicenter Study on the Efficacy and Safety of HES 130/0. 42 in a Balanced Electrolyte Solution vs a HES 130/0.4 in a Sodium Chloride Solution in Elective Surgery Patients
- Lead sponsor
- B. Braun Melsungen AG
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- July 31, 2011
- Enrollment
- 240 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
decreased and nonspecific blood pressure disorders and shock